The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies.
Stem cells unlock a range of treatment possibilities that have not previously been available to patients. While current treatment options rely on the body’s existing cells, stem cells can develop into many different cell types within the body – regenerating damaged tissues and organs or replacing dysfunctional and dead cells.
There are already promising potential applications in chronic diseases such as cancer, and metabolic diseases like diabetes. In future, stem cells could be used to alleviate currently untreatable conditions like dementia, fertility, and spinal cord injury.
Find out more information about CellVoyant here: CellVoyant — An ai-first biotechnology company on a mission to cure chronic diseases.